GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
What GAO Found By late March 2022, daily COVID-19 cases in the U.S. had fallen substantially since the Omicron-related peak in January 2022. Though COVID-19-associated hospitalizations and deaths have also decreased, the effects of the Omicron variant—and the rising prevalence of its new BA.
What GAO Found New U.S. COVID-19 cases and virus variants continue to challenge the nation. New daily reported cases increased sharply from December 21, 2021 to January 3, 2022 due primarily to the emergence of the Omicron variant.
What GAO Found As the lead for the nation's drug control efforts, the Office of National Drug Control Policy (ONDCP) posted drug control grant information to its website and is taking steps to ensure it is complete.
What GAO Found As the nation continues to respond to, and recover from, the COVID-19 pandemic, increases in COVID-19 cases in July, August, and September 2021, primarily due to the Delta variant of the virus, have hampered these efforts.
What GAO Found Regulations.gov and selected agency-specific comment websites collect some identity information, such as email address, from commenters who choose to provide it during the public comment process.
What GAO Found As of May 31, 2021, agencies obligated $61.4 billion for contracts in response to the COVID-19 pandemic. Agencies cancelled $4 billion in obligations, in some cases due to contract terminations.